Active Shortage

JAMP BRIMONIDINE/TIMOLOL

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP BRIMONIDINE/TIMOLOL in Canada?

Yes. JAMP BRIMONIDINE/TIMOLOL 0.2% 0.5% has an active shortage reported to Health Canada (last updated September 21, 2026).

Why is JAMP BRIMONIDINE/TIMOLOL not available?

The reason the manufacturer reported: Demand increase for the drug.

When will JAMP BRIMONIDINE/TIMOLOL be available again?

The manufacturer's estimated resolution date is November 6, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~39 days remaining (estimate)

Affected strength0.2% 0.5%

Last updated2026-09-21

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

APO-BRIMONIDINE-TIMOP

APO-BRIMONIDINE-TIMOP: The weight is out of specification in the affected lot.

Type II2026-03-05

Moderate health risk

Possible match — not confirmed

DIN

02531704

Strength

0.2% 0.5%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BRIMONIDINE TARTRATE TIMOLOL

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-21

Active Shortage

Demand increase for the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225

AMLODIPINE

5MG · DIN 02429217